157 related articles for article (PubMed ID: 14690459)
1. The diagnostic utility of p63, CK5/6, CK 7, and CK 20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas.
Qureshi HS; Ormsby AH; Lee MW; Zarbo RJ; Ma CK
J Cutan Pathol; 2004 Feb; 31(2):145-52. PubMed ID: 14690459
[TBL] [Abstract][Full Text] [Related]
2. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases.
Plaza JA; Ortega PF; Stockman DL; Suster S
J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin.
Mahalingam M; Nguyen LP; Richards JE; Muzikansky A; Hoang MP
Mod Pathol; 2010 May; 23(5):713-9. PubMed ID: 20190734
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarcinoma.
Plumb SJ; Argenyi ZB; Stone MS; De Young BR
Am J Dermatopathol; 2004 Dec; 26(6):447-51. PubMed ID: 15618924
[TBL] [Abstract][Full Text] [Related]
5. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin.
Ivan D; Nash JW; Prieto VG; Calonje E; Lyle S; Diwan AH; Lazar AJ
J Cutan Pathol; 2007 Jun; 34(6):474-80. PubMed ID: 17518775
[TBL] [Abstract][Full Text] [Related]
6. p40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases.
Lee JJ; Mochel MC; Piris A; Boussahmain C; Mahalingam M; Hoang MP
Hum Pathol; 2014 May; 45(5):1078-83. PubMed ID: 24746214
[TBL] [Abstract][Full Text] [Related]
7. PAX8 discriminates ovarian metastases from adnexal tumors and other cutaneous metastases.
Fujiwara M; Taube J; Sharma M; McCalmont TH; Kim J
J Cutan Pathol; 2010 Sep; 37(9):938-43. PubMed ID: 20492080
[TBL] [Abstract][Full Text] [Related]
8. Sox10 and DOG1 Expression in Primary Adnexal Tumors of the Skin.
Lezcano C; Ho J; Seethala RR
Am J Dermatopathol; 2017 Dec; 39(12):896-902. PubMed ID: 28394798
[TBL] [Abstract][Full Text] [Related]
9. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin.
Ivan D; Hafeez Diwan A; Prieto VG
Mod Pathol; 2005 Jan; 18(1):137-42. PubMed ID: 15389254
[TBL] [Abstract][Full Text] [Related]
10. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
Buonaccorsi JN; Plaza JA
Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous adnexal tumor with an unusual presentation--discussion of a potential diagnostic pitfall.
Cangelosi JJ; Nash JW; Prieto VG; Ivan D
Am J Dermatopathol; 2009 May; 31(3):278-81. PubMed ID: 19384070
[TBL] [Abstract][Full Text] [Related]
12. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray.
Reis-Filho JS; Simpson PT; Martins A; Preto A; Gärtner F; Schmitt FC
Virchows Arch; 2003 Aug; 443(2):122-32. PubMed ID: 12884041
[TBL] [Abstract][Full Text] [Related]
13. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.
Liang H; Wu H; Giorgadze TA; Sariya D; Bellucci KS; Veerappan R; Liegl B; Acs G; Elenitsas R; Shukla S; Youngberg GA; Coogan PS; Pasha T; Zhang PJ; Xu X
Am J Surg Pathol; 2007 Feb; 31(2):304-10. PubMed ID: 17255777
[TBL] [Abstract][Full Text] [Related]
14. The usefulness of p63 detection for differentiating primary from metastatic skin adenocarcinomas.
Ivan D; Diwan AH; Lazar AJ; Prieto VG
J Cutan Pathol; 2008 Sep; 35(9):880-1. PubMed ID: 18796086
[No Abstract] [Full Text] [Related]
15. Immunohistochemical distinction of primary sweat gland carcinoma and metastatic breast carcinoma: can it always be accomplished reliably?
Mentrikoski MJ; Wick MR
Am J Clin Pathol; 2015 Mar; 143(3):430-6. PubMed ID: 25696802
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas.
Kargi A; Gurel D; Tuna B
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):415-20. PubMed ID: 18091384
[TBL] [Abstract][Full Text] [Related]
17. Challenges in the diagnosis of cutaneous adnexal tumours.
Danialan R; Mutyambizi K; Aung P; Prieto VG; Ivan D
J Clin Pathol; 2015 Dec; 68(12):992-1002. PubMed ID: 26602416
[TBL] [Abstract][Full Text] [Related]
18. Luminal cytokeratin expression profiles of breast papillomas and papillary carcinomas and the utility of a cytokeratin 5/p63/cytokeratin 8/18 antibody cocktail in their distinction.
Reisenbichler ES; Balmer NN; Adams AL; Pfeifer JD; Hameed O
Mod Pathol; 2011 Feb; 24(2):185-93. PubMed ID: 21076459
[TBL] [Abstract][Full Text] [Related]
19. The Utility of Myoepithelial Cell Layer Identification in Adnexal Carcinomas.
Plaza JA; Chung C; Wick M; Sangueza M; Gru A
Am J Dermatopathol; 2022 Mar; 44(3):155-162. PubMed ID: 35171883
[TBL] [Abstract][Full Text] [Related]
20. GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms.
Mertens RB; de Peralta-Venturina MN; Balzer BL; Frishberg DP
Am J Dermatopathol; 2015 Dec; 37(12):885-91. PubMed ID: 26595821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]